查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球放射免疫分析市場:行業趨勢和預測（至 2030 年）
市場調查報告書
商品編碼
1189444

全球放射免疫分析市場:行業趨勢和預測（至 2030 年）

Global Radioimmunoassay Market - Industry Trends and Forecast to 2030
出版日期: | 出版商: Data Bridge Market Research | 英文 471 Pages | 商品交期: 請詢問到貨日

價格

在 2023 年至 2030 年的預測期內，全球放射免疫分析市場規模預計將實現 4.1% 的複合年增長率。

在高通量和自動化流程的推動下，對無差錯和準確結果的需求不斷增加，技術不斷進步，市場進入者採取戰略舉措，醫學研究和開發的重要性不斷提高，這些都在推動全球放射免疫分析的發展。市場的主要增長動力。

本報告研究和分析全球放射免疫分析市場，提供系統信息，包括市場概況、按細分市場和地區劃分的市場分析、競爭分析和公司概況。

內容

第一章介紹

第 2 章市場細分

第 3 章執行摘要

第 4 章重要注意事項

  • PESTEL 分析
  • 波特五力模型
  • 主要市場公司採用的增長戰略

第 5 章行業洞察

第 6 章放射免疫測定法規指南

  • 美國
  • 歐洲
  • 印度
  • 中國

第 7 章市場概述

  • 司機
    • 由於高通量和自動化流程，對無差錯、準確結果的需求增加
    • 傳染病的患病率和發病率上升
    • 不斷進步的技術進步
  • 約束因素
    • 放射免疫測定試劑盒的安裝和維護成本高
    • 放射性標記化合物的保質期短
    • 有害放射性元素的不利影響
  • 機會
    • 增加醫學研究和開發的重要性
    • 增加政府資助和整體醫療保健支出
    • 市場公司的戰略舉措
  • 任務
    • 缺乏熟練的專業人員
    • 各種其他免疫測定方法的新創新

第 8 章。全球放射免疫分析市場:按產品類型分類

  • 概覽
  • 放射免疫分析試劑和試劑盒
    • 工具包
    • 緩衝區
    • 標準濃縮液
    • 沉澱試劑
    • 放射性同位素
    • 抗體和抗血清
    • 其他
  • 放射免疫分析儀

第 9 章全球放射免疫分析市場:按應用

  • 概覽
  • 科學研究
    • 放射免疫分析試劑和試劑盒
    • 放射免疫分析儀
  • 臨床診斷
    • 傳染病檢測
    • 過敏測試
    • 腫瘤學檢查
    • 內分泌測試
    • 毒性測試
    • 自身免疫性疾病測試
    • 其他疾病檢查

第 10 章全球放射免疫分析市場:按最終用戶分類

  • 概覽
  • 醫院
  • 臨床診斷實驗室
  • 學術和研究機構
  • 製藥和生物製藥行業
  • 委託研究機構
  • 其他

第 11 章全球放射免疫分析市場:按分銷渠道

  • 概覽
  • 直接投標
  • 在線銷售
  • 第三方分發
  • 其他

第 12 章全球放射免疫分析市場:按地區

  • 概覽
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
    • 俄羅斯
    • 土耳其
    • 荷蘭
    • 比利時
    • 瑞士
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳大利亞
    • 印度尼西亞
    • 菲律賓
    • 泰國
    • 馬來西亞
    • 新加坡
    • 其他亞太地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 埃及
    • 以色列
    • 其他中東/非洲

第 13 章全球放射免疫分析市場:公司概況

  • 公司份額分析:世界
  • 公司份額分析:北美
  • 公司份額分析:歐洲
  • 公司份額分析:亞太地區

第 14 章 SWOT 分析

第十五章公司簡介

  • PERKINELMER INC.
  • MERCK KGAA
  • BECKMAN COULTER, INC.
  • ABCAM PLC
  • TECAN TRADING AG
  • BERTHOLD TECHNOLOGIES GMBH & CO.KG
  • DEMEDITEC DIAGNOSTICS GMBH
  • DIASOURCE
  • EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG
  • HIDEX OY
  • IMMUNO-BIOLOGICAL LABORATORIES CO,LTD.
  • INSTITUTE OF ISOTOPES
  • KAMIYA BIOMEDICAL COMPANY
  • MP BIOMEDICALS
  • MYBIOSOURCE.COM.

第16章問卷調查

第十七章相關報導

Global radioimmunoassay market is projected to register a substantial CAGR of 4.1% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Global Radioimmunoassay Market, By Product Type (Radio Immunoassay Reagents and Kits and Radio Immunoassay Analyser), Application (Scientific Research and Clinical Diagnosis), End User (Hospitals, Clinical Diagnostic Laboratories, Academic and Research Institutes, Pharmaceutical and Biopharmaceutical Industry, Contract Research Organizations, and Other), Distribution Channel (Direct Tender, Online Sales, Third Party Distribution, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K, Italy, Spain, Russia, Turkey, Belgium, Denmark, Netherlands, Switzerland, Sweden, Poland, Norway, Finland, Rest of Europe, China, Japan, India, South Korea, Australia, Indonesia, Philippines, Thailand, Malaysia, Singapore Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, and Rest of Middle East and Africa) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of global radioimmunoassay market are:

Increase in the demand for error-free and accurate results of high throughput and automated procedures

Rise in the technological advancements

Strategic initiatives by market players

Increasing significance of research and development in medical science

Market Players:

The key market players in global radioimmunoassay market are listed below:

PerkinElmer Inc.

MP BIOMEDICALS

Tecan Trading AG

Merck KGaA

Immuno-Biological Laboratories Co,Ltd.

EUROIMMUN Medizinische Labordiagnostika AG

KAMIYA BIOMEDICAL COMPANY

Beckman Coulter, Inc.

Demeditec Diagnostics GmbH

MyBioSource.com.

DiaSource

Berthold Technologies GmbH & Co.KG

Hidex Oy.

Institute of Isotopes

Abcam plc

TABLE OF CONTENTS

1 INTRODUCTION 66

  • 1.1 OBJECTIVES OF THE STUDY 66
  • 1.2 MARKET DEFINITION 66
  • 1.3 OVERVIEW OF GLOBAL RADIOIMMUNOASSAY MARKET 66
  • 1.4 LIMITATIONS 68
  • 1.5 MARKETS COVERED 68

2 MARKET SEGMENTATION 72

  • 2.1 MARKETS COVERED 72
  • 2.2 GEOGRAPHICAL SCOPE 73
  • 2.3 YEARS CONSIDERED FOR THE STUDY 74
  • 2.4 CURRENCY AND PRICING 74
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 75
  • 2.6 MULTIVARIATE MODELLING 78
  • 2.7 PRODUCT TYPE LIFELINE CURVE 78
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 79
  • 2.9 DBMR MARKET POSITION GRID 80
  • 2.10 MARKET TESTING TYPE COVERAGE GRID 82
  • 2.11 VENDOR SHARE ANALYSIS 83
  • 2.12 SECONDARY SOURCES 84
  • 2.13 ASSUMPTIONS 84

3 EXECUTIVE SUMMARY 85

4 PREMIUM INSIGHTS 88

  • 4.1 PESTEL ANALYSIS 91
  • 4.2 PORTYER'S FIVE FORCES 92
  • 4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 93

5 INDUSTRY INSIGHTS: 94

6 REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 95

  • 6.1 U.S REGULATORY GUIDELINES FOR RADIOIMMUNOASSAY 95
  • 6.2 EUROPE REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 95
  • 6.3 INDIA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 96
  • 6.4 CHINA REGULATORY GUIDELINE FOR RADIOIMMUNOASSAY 97

7 MARKET OVERVIEW 98

  • 7.1 DRIVERS 100
    • 7.1.1 INCREASE IN THE DEMAND FOR ERROR-FREE AND ACCURATE RESULTS OF HIGH THROUGHPUT AND AUTOMATED PROCEDURES 100
    • 7.1.2 RISE IN THE PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES 100
    • 7.1.3 RISE IN THE TECHNOLOGICAL ADVANCEMENTS 101
  • 7.2 RESTRAINTS 101
    • 7.2.1 HIGH COST OF INSTALLATION AND MAINTENANCE OF RADIOIMMUNOASSAY KITS 101
    • 7.2.2 SHORT SHELF-LIFE OF RADIOLABELED COMPOUNDS 102
    • 7.2.3 ADVERSE EFFECTS OF HAZARDOUS RADIOACTIVE ELEMENTS 102
  • 7.3 OPPORTUNITIES 103
    • 7.3.1 INCREASING SIGNIFICANCE OF RESEARCH AND DEVELOPMENT IN MEDICAL SCIENCE 103
    • 7.3.2 RISE IN GOVERNMENT FUNDING AND OVERALL HEALTHCARE EXPENDITURE 103
    • 7.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS 104
  • 7.4 CHALLENGES 106
    • 7.4.1 LACK OF SKILLED PROFESSIONALS 106
    • 7.4.2 NEW INNOVATIONS IN VARIOUS OTHER IMMUNOASSAY PROCEDURES 106

8 GLOBAL RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 107

  • 8.1 OVERVIEW 108
  • 8.2 RADIOIMMUNOASSAY REAGENTS AND KITS 111
    • 8.2.1 KITS 112
    • 8.2.2 BUFFER 112
      • 8.2.2.1 SOLUTION 112
      • 8.2.2.2 POWDER 112
    • 8.2.3 STANDARD CONCENTRATES 113
    • 8.2.4 PRECIPITATING REAGENTS 113
    • 8.2.5 RADIOISOTOPES 113
      • 8.2.5.1 BETA EMITTERS 113
        • 8.2.5.1.1 TRITIUM 113
        • 8.2.5.1.2 CARBON-14 114
      • 8.2.5.2 GAMMA EMITTERS 114
        • 8.2.5.2.1 IODINE-125 114
        • 8.2.5.2.2 CHROMIUM-51 114
        • 8.2.5.2.3 COBALT-57 114
    • 8.2.6 ANTIBODY/ANTISERUM 115
      • 8.2.6.1 POLYCLONAL 115
      • 8.2.6.2 MONOCLONAL 115
    • 8.2.7 OTHERS 115
  • 8.3 RADIOIMMUNOASSAY ANALYZER 116

9 GLOBAL RADIOIMMUNOASSAY MARKET: BY APPLICATION 117

  • 9.1 OVERVIEW 118
  • 9.2 SCIENTIFIC RESEARCH 121
    • 9.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 122
    • 9.2.2 RADIOIMMUNOASSAY ANALYZER 122
  • 9.3 CLINICAL DIAGNOSIS 122
    • 9.3.1 INFECTIOUS DISEASE TESTING 123
      • 9.3.1.1 RADIOIMMUNOASSAY REAGENTS AND KITS 123
      • 9.3.1.2 RADIOIMMUNOASSAY ANALYZER 123
    • 9.3.2 ALLERGY TESTING 124
      • 9.3.2.1 RADIOIMMUNOASSAY REAGENTS AND KITS 124
      • 9.3.2.2 RADIOIMMUNOASSAY ANALYZER 124
    • 9.3.3 ONCOLOGY TESTING 124
      • 9.3.3.1 RADIOIMMUNOASSAY REAGENTS AND KITS 124
      • 9.3.3.2 RADIOIMMUNOASSAY ANALYZER 125
    • 9.3.4 ENDOCRINE TESTING 125
      • 9.3.4.1 RADIOIMMUNOASSAY REAGENTS AND KITS 125
      • 9.3.4.2 RADIOIMMUNOASSAY ANALYZER 125
    • 9.3.5 TOXICOLOGY TESTING 126
      • 9.3.5.1 RADIOIMMUNOASSAY REAGENTS AND KITS 126
      • 9.3.5.2 RADIOIMMUNOASSAY ANALYZER 126
    • 9.3.6 AUTOIMMUNE DISEASE TESTING 126
      • 9.3.6.1 RADIOIMMUNOASSAY REAGENTS AND KITS 127
      • 9.3.6.2 RADIOIMMUNOASSAY ANALYZER 127
    • 9.3.7 OTHER DISEASE TESTING 127

10 GLOBAL RADIOIMMUNOASSAY MARKET, BY END USER 128

  • 10.1 OVERVIEW 129
  • 10.2 HOSPITALS 132
  • 10.3 CLINICAL DIAGNOSTIC LABORATORIES 132
  • 10.4 ACADEMIC AND RESEARCH INSTITUTES 133
  • 10.5 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 134
  • 10.6 CONTRACT RESEARCH ORGANISATIONS 134
  • 10.7 OTHERS 135

11 GLOBAL RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL 136

  • 11.1 OVERVIEW 137
  • 11.2 DIRECT TENDER 140
  • 11.3 ONLINE SALES 141
  • 11.4 THIRD PARTY DISTRIBUTIONS 142
  • 11.5 OTHERS 143

12 GLOBAL RADIOIMMUNOASSAY MARKET, BY REGION 144

  • 12.1 OVERVIEW 145
  • 12.2 NORTH AMERICA 150
    • 12.2.1 U.S. 162
    • 12.2.2 CANADA 169
    • 12.2.3 MEXICO 176
  • 12.3 EUROPE 183
    • 12.3.1 GERMANY 195
    • 12.3.2 FRANCE 203
    • 12.3.3 U.K. 210
    • 12.3.4 ITALY 217
    • 12.3.5 SPAIN 224
    • 12.3.6 RUSSIA 231
    • 12.3.7 TURKEY 238
    • 12.3.8 NETHERLANDS 245
    • 12.3.9 BELGIUM 252
    • 12.3.10 SWITZERLAND 260
    • 12.3.11 REST OF EUROPE 267
  • 12.4 ASIA-PACIFIC 268
    • 12.4.1 CHINA 280
    • 12.4.2 JAPAN 287
    • 12.4.3 INDIA 294
    • 12.4.4 SOUTH KOREA 302
    • 12.4.5 AUSTRALIA 310
    • 12.4.6 INDONESIA 318
    • 12.4.7 PHILIPPINES 325
    • 12.4.8 THAILAND 333
    • 12.4.9 MALAYSIA 341
    • 12.4.10 SINGAPORE 348
    • 12.4.11 REST OF ASIA-PACIFIC 356
  • 12.5 SOUTH AMERICA 357
    • 12.5.1 BRAZIL 368
    • 12.5.2 ARGENTINA 375
    • 12.5.3 REST OF SOUTH AMERICA 382
  • 12.6 MIDDLE EAST AND AFRICA 383
    • 12.6.1 SOUTH AFRICA 395
    • 12.6.2 SAUDI ARABIA 402
    • 12.6.3 UAE 409
    • 12.6.4 EGYPT 417
    • 12.6.5 ISRAEL 425
    • 12.6.6 REST OF MIDDLE EAST AND AFRICA 433

13 GLOBAL RADIOIMMUNOASSAY MARKET: COMPANY LANDSCAPE 434

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL 434
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 435
  • 13.3 COMPANY SHARE ANALYSIS: EUROPE 436
  • 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 437

14 SWOT ANALYSIS 438

15 COMPANY PROFILE 439

  • 15.1 PERKINELMER INC. 439
    • 15.1.1 COMPANY SNAPSHOT 439
    • 15.1.2 REVENUE ANALYSIS 439
    • 15.1.3 COMPANY SHARE ANALYSIS 440
    • 15.1.4 PRODUCT PORTFOLIO 440
    • 15.1.4 RECENT DEVELOPMENT 441
  • 15.2 MERCK KGAA 442
    • 15.2.1 COMPANY SNAPSHOT 442
    • 15.2.2 REVENUE ANALYSIS 442
    • 15.2.3 COMPANY SHARE ANALYSIS 443
    • 15.2.4 PRODUCT PORTFOLIO 443
    • 15.2.5 RECENT DEVELOPMENTS 443
  • 15.3 BECKMAN COULTER, INC. 445
    • 15.3.1 COMPANY SNAPSHOT 445
    • 15.3.2 COMPANY SHARE ANALYSIS 445
    • 15.3.3 PRODUCT PORTFOLIO 445
    • 15.3.4 RECENT DEVELOPMENT 446
  • 15.4 ABCAM PLC 447
    • 15.4.1 COMPANY SNAPSHOT 447
    • 15.4.2 REVENUE ANALYSIS 447
    • 15.4.3 COMPANY SHARE ANALYSIS 448
    • 15.4.4 PRODUCT PORTFOLIO 448
    • 15.4.5 RECENT DEVELOPMENT 448
  • 15.5 TECAN TRADING AG 449
    • 15.5.1 COMPANY SNAPSHOT 449
    • 15.5.2 REVENUE ANALYSIS 449
    • 15.5.3 COMPANY SHARE ANALYSIS 450
    • 15.5.4 PRODUCT PORTFOLIO 450
    • 15.5.5 RECENT DEVELOPMENT 451
  • 15.6 BERTHOLD TECHNOLOGIES GMBH & CO.KG 452
    • 15.6.1 COMPANY SNAPSHOT 452
    • 15.6.2 PRODUCT PORTFOLIO 452
    • 15.6.3 RECENT DEVELOPMENTS 452
  • 15.7 DEMEDITEC DIAGNOSTICS GMBH 453
    • 15.7.1 COMPANY SNAPSHOT 453
    • 15.7.2 PRODUCT PORTFOLIO 453
    • 15.7.3 RECENT DEVELOPMENTS 454
  • 15.8 DIASOURCE 455
    • 15.8.1 COMPANY SNAPSHOT 455
    • 15.8.2 PRODUCT PORTFOLIO 455
    • 15.8.3 RECENT DEVELOPMENT 455
  • 15.9 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 456
    • 15.9.1 COMPANY SNAPSHOT 456
    • 15.9.2 PRODUCT PORTFOLIO 456
    • 15.9.3 RECENT DEVELOPMENTS 456
  • 15.10 HIDEX OY 458
    • 15.10.1 COMPANY SNAPSHOT 458
    • 15.10.2 PRODUCT PORTFOLIO 458
    • 15.10.3 RECENT DEVELOPMENTS 458
  • 15.11 IMMUNO-BIOLOGICAL LABORATORIES CO,LTD. 459
    • 15.11.1 COMPANY SNAPSHOT 459
    • 15.11.2 PRODUCT PORTFOLIO 459
    • 15.11.3 RECENT DEVELOPMENT 461
  • 15.12 INSTITUTE OF ISOTOPES 462
    • 15.12.1 COMPANY SNAPSHOT 462
    • 15.12.2 PRODUCT PORTFOLIO 462
    • 15.12.3 RECENT DEVELOPMENTS 463
  • 15.13 KAMIYA BIOMEDICAL COMPANY 464
    • 15.13.1 COMPANY SNAPSHOT 464
    • 15.13.2 PRODUCT PORTFOLIO 464
    • 15.13.3 RECENT DEVELOPMENTS 464
  • 15.14 MP BIOMEDICALS 465
    • 15.14.1 COMPANY SNAPSHOT 465
    • 15.14.2 PRODUCT PORTFOLIO 465
    • 15.14.3 RECENT DEVELOPMENTS 466
  • 15.15 MYBIOSOURCE.COM. 467
    • 15.15.1 COMPANY SNAPSHOT 467
    • 15.15.2 PRODUCT PORTFOLIO 467
    • 15.15.3 RECENT DEVELOPMENT 467

16 QUESTIONNAIRE 468

17 RELATED REPORTS 471

LIST OF TABLES

  • TABLE 1 LIST OF IN-VITRO DIAGNOSTIC MEDICAL DEVICES (IVD ANALYZERS) UNDER PROVISIONS OF SUB-RULE (2) RULE 4 OF THE MEDICAL DEVICES RULES, 2017 96
  • TABLE 2 COST OF RIA KITS IS MENTIONED BELOW 101
  • TABLE 3 DECOMPOSITION RATES OF A FEW RADIOLABELED ISOTOPES ARE MENTIONED IN THE BELOW TABLE 102
  • TABLE 4 GLOBAL RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 110
  • TABLE 5 GLOBAL RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 111
  • TABLE 6 GLOBAL RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
  • TABLE 7 GLOBAL BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 112
  • TABLE 8 GLOBAL RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
  • TABLE 9 GLOBAL BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 113
  • TABLE 10 GLOBAL GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 114
  • TABLE 11 GLOBAL ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 115
  • TABLE 12 GLOBAL RADIOIMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 13 GLOBAL RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 120
  • TABLE 14 GLOBAL SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 121
  • TABLE 15 GLOBAL SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 121
  • TABLE 16 GLOBAL CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 122
  • TABLE 17 GLOBAL CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 123
  • TABLE 18 GLOBAL INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 19 GLOBAL ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 20 GLOBAL ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 21 GLOBAL ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 22 GLOBAL TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 126
  • TABLE 23 GLOBAL AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 24 GLOBAL RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 131
  • TABLE 25 GLOBAL HOSPITALS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 132
  • TABLE 26 GLOBAL CLINICAL DIAGNOSTIC LABORATORIES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 133
  • TABLE 27 GLOBAL ACADEMIC AND RESEARCH INSTITUTES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 133
  • TABLE 28 GLOBAL PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 134
  • TABLE 29 GLOBAL CONTRACT RESEARCH ORGANISATIONS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 135
  • TABLE 30 GLOBAL OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 135
  • TABLE 31 GLOBAL RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 139
  • TABLE 32 GLOBAL DIRECT TENDER IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 140
  • TABLE 33 GLOBAL ONLINE SALES IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 141
  • TABLE 34 GLOBAL THIRD PARTY DISTRIBUTION IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 142
  • TABLE 35 GLOBAL OTHERS IN RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 143
  • TABLE 36 GLOBAL RADIOIMMUNOASSAY MARKET, BY REGION, 2021-2030 (USD MILLION) 149
  • TABLE 37 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 154
  • TABLE 38 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 39 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 154
  • TABLE 40 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 155
  • TABLE 41 NORTH AMERICA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 155
  • TABLE 42 NORTH AMERICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155
  • TABLE 43 NORTH AMERICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 155
  • TABLE 44 NORTH AMERICA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 155
  • TABLE 45 NORTH AMERICA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 46 NORTH AMERICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 47 NORTH AMERICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 156
  • TABLE 48 NORTH AMERICA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 156
  • TABLE 49 NORTH AMERICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 156
  • TABLE 50 NORTH AMERICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 157
  • TABLE 51 NORTH AMERICA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 157
  • TABLE 52 NORTH AMERICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 157
  • TABLE 53 NORTH AMERICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 157
  • TABLE 54 NORTH AMERICA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 157
  • TABLE 55 NORTH AMERICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 158
  • TABLE 56 NORTH AMERICA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 158
  • TABLE 57 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 158
  • TABLE 58 NORTH AMERICA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 158
  • TABLE 59 NORTH AMERICA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 159
  • TABLE 60 NORTH AMERICA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 61 NORTH AMERICA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 159
  • TABLE 62 NORTH AMERICA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 63 NORTH AMERICA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 64 NORTH AMERICA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 160
  • TABLE 65 NORTH AMERICA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 160
  • TABLE 66 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 161
  • TABLE 67 NORTH AMERICA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 161
  • TABLE 68 U.S. RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 69 U.S. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 162
  • TABLE 70 U.S. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 162
  • TABLE 71 U.S. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 163
  • TABLE 72 U.S. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 73 U.S. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 163
  • TABLE 74 U.S. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 163
  • TABLE 75 U.S. RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 163
  • TABLE 76 U.S. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 77 U.S. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 164
  • TABLE 78 U.S. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 164
  • TABLE 79 U.S. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 164
  • TABLE 80 U.S. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 164
  • TABLE 81 U.S. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 165
  • TABLE 82 U.S. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 165
  • TABLE 83 U.S. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 165
  • TABLE 84 U.S. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 165
  • TABLE 85 U.S. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 165
  • TABLE 86 U.S. RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 166
  • TABLE 87 U.S. RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
  • TABLE 88 U.S. SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 166
  • TABLE 89 U.S. CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 166
  • TABLE 90 U.S. INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 91 U.S. ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 92 U.S. ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 93 U.S. ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 167
  • TABLE 94 U.S. TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 168
  • TABLE 95 U.S. AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 168
  • TABLE 96 U.S. RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 168
  • TABLE 97 U.S. RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 168
  • TABLE 98 CANADA RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 99 CANADA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 169
  • TABLE 100 CANADA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 169
  • TABLE 101 CANADA RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 170
  • TABLE 102 CANADA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 103 CANADA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 170
  • TABLE 104 CANADA BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 170
  • TABLE 105 CANADA RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 170
  • TABLE 106 CANADA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 107 CANADA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 171
  • TABLE 108 CANADA BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 171
  • TABLE 109 CANADA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 171
  • TABLE 110 CANADA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 171
  • TABLE 111 CANADA GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 172
  • TABLE 112 CANADA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 172
  • TABLE 113 CANADA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 172
  • TABLE 114 CANADA ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 172
  • TABLE 115 CANADA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 172
  • TABLE 116 CANADA RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 173
  • TABLE 117 CANADA RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 173
  • TABLE 118 CANADA SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 173
  • TABLE 119 CANADA CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 173
  • TABLE 120 CANADA INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 121 CANADA ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 122 CANADA ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 123 CANADA ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 174
  • TABLE 124 CANADA TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 175
  • TABLE 125 CANADA AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 175
  • TABLE 126 CANADA RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 175
  • TABLE 127 CANADA RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 175
  • TABLE 128 MEXICO RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 176
  • TABLE 129 MEXICO RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 176
  • TABLE 130 MEXICO RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 176
  • TABLE 131 MEXICO RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 177
  • TABLE 132 MEXICO BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 133 MEXICO BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 177
  • TABLE 134 MEXICO BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 177
  • TABLE 135 MEXICO RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 177
  • TABLE 136 MEXICO BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 178
  • TABLE 137 MEXICO BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 178
  • TABLE 138 MEXICO BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 178
  • TABLE 139 MEXICO GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 178
  • TABLE 140 MEXICO GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 178
  • TABLE 141 MEXICO GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 179
  • TABLE 142 MEXICO ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 179
  • TABLE 143 MEXICO ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 179
  • TABLE 144 MEXICO ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 179
  • TABLE 145 MEXICO RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 179
  • TABLE 146 MEXICO RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 180
  • TABLE 147 MEXICO RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 180
  • TABLE 148 MEXICO SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 180
  • TABLE 149 MEXICO CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 180
  • TABLE 150 MEXICO INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 151 MEXICO ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 152 MEXICO ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 153 MEXICO ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 181
  • TABLE 154 MEXICO TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 182
  • TABLE 155 MEXICO AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 182
  • TABLE 156 MEXICO RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 182
  • TABLE 157 MEXICO RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 182
  • TABLE 158 EUROPE RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 187
  • TABLE 159 EUROPE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 160 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 187
  • TABLE 161 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 188
  • TABLE 162 EUROPE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 188
  • TABLE 163 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 188
  • TABLE 164 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 188
  • TABLE 165 EUROPE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 188
  • TABLE 166 EUROPE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 167 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 168 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 189
  • TABLE 169 EUROPE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 189
  • TABLE 170 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 189
  • TABLE 171 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 190
  • TABLE 172 EUROPE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 190
  • TABLE 173 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 190
  • TABLE 174 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 190
  • TABLE 175 EUROPE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 190
  • TABLE 176 EUROPE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 191
  • TABLE 177 EUROPE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 191
  • TABLE 178 EUROPE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 191
  • TABLE 179 EUROPE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 191
  • TABLE 180 EUROPE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 192
  • TABLE 181 EUROPE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 182 EUROPE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 183 EUROPE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 192
  • TABLE 184 EUROPE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 185 EUROPE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 193
  • TABLE 186 EUROPE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 193
  • TABLE 187 EUROPE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 193
  • TABLE 188 EUROPE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 194
  • TABLE 189 GERMANY RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 195
  • TABLE 190 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 195
  • TABLE 191 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 195
  • TABLE 192 GERMANY RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 196
  • TABLE 193 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
  • TABLE 194 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 196
  • TABLE 195 GERMANY BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 196
  • TABLE 196 GERMANY RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 196
  • TABLE 197 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 197
  • TABLE 198 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 197
  • TABLE 199 GERMANY BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 197
  • TABLE 200 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 197
  • TABLE 201 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 198
  • TABLE 202 GERMANY GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 198
  • TABLE 203 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 198
  • TABLE 204 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 198
  • TABLE 205 GERMANY ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 198
  • TABLE 206 GERMANY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 199
  • TABLE 207 GERMANY RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 199
  • TABLE 208 GERMANY RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 199
  • TABLE 209 GERMANY SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 199
  • TABLE 210 GERMANY CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 200
  • TABLE 211 GERMANY INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 200
  • TABLE 212 GERMANY ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 200
  • TABLE 213 GERMANY ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 201
  • TABLE 214 GERMANY ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 201
  • TABLE 215 GERMANY TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 201
  • TABLE 216 GERMANY AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 201
  • TABLE 217 GERMANY RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 202
  • TABLE 218 GERMANY RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 202
  • TABLE 219 FRANCE RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 203
  • TABLE 220 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 203
  • TABLE 221 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 203
  • TABLE 222 FRANCE RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 204
  • TABLE 223 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 204
  • TABLE 224 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 204
  • TABLE 225 FRANCE BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 204
  • TABLE 226 FRANCE RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 204
  • TABLE 227 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 205
  • TABLE 228 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 205
  • TABLE 229 FRANCE BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 205
  • TABLE 230 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 205
  • TABLE 231 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 205
  • TABLE 232 FRANCE GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 206
  • TABLE 233 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 206
  • TABLE 234 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 206
  • TABLE 235 FRANCE ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 206
  • TABLE 236 FRANCE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 206
  • TABLE 237 FRANCE RADIO IMMUNO ANALYZERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 207
  • TABLE 238 FRANCE RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 207
  • TABLE 239 FRANCE SCIENTIFIC RESEARCH IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 207
  • TABLE 240 FRANCE CLINICAL DIAGNOSIS IN RADIOIMMUNOASSAY MARKET, BY APPLICATION, 2021-2030 (USD MILLION) 207
  • TABLE 241 FRANCE INFECTIOUS DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 208
  • TABLE 242 FRANCE ALLERGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 208
  • TABLE 243 FRANCE ONCOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 208
  • TABLE 244 FRANCE ENDOCRINE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 208
  • TABLE 245 FRANCE TOXICOLOGY TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION) 209
  • TABLE 246 FRANCE AUTOIMMUNE DISEASE TESTING IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 209
  • TABLE 247 FRANCE RADIOIMMUNOASSAY MARKET, BY END USER, 2021-2030 (USD MILLION) 209
  • TABLE 248 FRANCE RADIOIMMUNOASSAY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 209
  • TABLE 249 U.K. RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 210
  • TABLE 250 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 210
  • TABLE 251 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 210
  • TABLE 252 U.K. RADIOIMMUNOASSAY REAGENTS AND KITS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 211
  • TABLE 253 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 211
  • TABLE 254 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 211
  • TABLE 255 U.K. BUFFER IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 211
  • TABLE 256 U.K. RADIOISOTOPES IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 211
  • TABLE 257 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 212
  • TABLE 258 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 212
  • TABLE 259 U.K. BETA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 212
  • TABLE 260 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 212
  • TABLE 261 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (VOLUME) 212
  • TABLE 262 U.K. GAMMA EMITTERS IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030 (ASP IN USD) 213
  • TABLE 263 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(USD MILLION) 213
  • TABLE 264 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(VOLUME) 213
  • TABLE 265 U.K. ANTIBODY/ANTISERUM IN RADIOIMMUNOASSAY MARKET, BY PRODUCT TYPE, 2021-2030(ASP IN USD) 213

LIST OF FIGURES

  • FIGURE 1 GLOBAL RADIOIMMUNOASSAY MARKET: SEGMENTATION 72
  • FIGURE 2 GLOBAL RADIOIMMUNOASSAY MARKET: DATA TRIANGULATION 75
  • FIGURE 3 GLOBAL RADIOIMMUNOASSAY MARKET: DROC ANALYSIS 76
  • FIGURE 4 GLOBAL RADIOIMMUNOASSAY MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 77
  • FIGURE 5 GLOBAL RADIOIMMUNOASSAY: COMPANY RESEARCH ANALYSIS 77
  • FIGURE 6 GLOBAL RADIOIMMUNOASSAY MARKET: INTERVIEW DEMOGRAPHICS 79
  • FIGURE 7 GLOBAL RADIOIMMUNOASSAY MARKET: DBMR MARKET POSITION GRID 80
  • FIGURE 8 GLOBAL RADIOIMMUNOASSAY MARKET: MARKET TESTING TYPE COVERAGE GRID 82
  • FIGURE 9 GLOBAL RADIOIMMUNOASSAY MARKET: VENDOR SHARE ANALYSIS 83
  • FIGURE 10 GLOBAL RADIOIMMUNOASSAY MARKET: SEGMENTATION 87
  • FIGURE 11 RISING PREVALENCE AND INCIDENCE OF INFECTIOUS DISEASES ARE EXPECTED TO DRIVE THE GLOBAL RADIOIMMUNOASSAY MARKET IN THE FORECAST PERIOD 88
  • FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL RADIOIMMUNOASSAY MARKET IN 2023 & 2030 88
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL RADIOIMMUNOASSAY MARKET, AND EUROPE IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD 89
  • FIGURE 14 EUROPE IS THE FASTEST-GROWING MARKET FOR GLOBAL RADIOIMMUNOASSAY MARKET MANUFACTURERS IN THE FORECAST PERIOD 90
  • FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE GLOBAL RADIOIMMUNOASSAY MARKET 99
  • FIGURE 16 GLOBAL RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2022 108
  • FIGURE 17 GLOBAL RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 109
  • FIGURE 18 GLOBAL RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 109
  • FIGURE 19 GLOBAL RADIOIMMUNOASSAY MARKET: PRODUCT TYPE, LIFELINE CURVE 110
  • FIGURE 20 GLOBAL RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2022 118
  • FIGURE 21 GLOBAL RADIOIMMUNOASSAY MARKET: BY APPLICATION, 2023-2030 (USD MILLION) 119
  • FIGURE 22 GLOBAL RADIOIMMUNOASSAY MARKET: BY APPLICATION, CAGR (2023-2030) 119
  • FIGURE 23 GLOBAL RADIOIMMUNOASSAY MARKET: BY APPLICATION, LIFELINE CURVE 120
  • FIGURE 24 GLOBAL RADIOIMMUNOASSAY MARKET: BY END USER, 2022 129
  • FIGURE 25 GLOBAL RADIOIMMUNOASSAY MARKET: BY END USER, 2023-2030 (USD MILLION) 130
  • FIGURE 26 GLOBAL RADIOIMMUNOASSAY MARKET: BY END USER, CAGR (2023-2030) 130
  • FIGURE 27 GLOBAL RADIOIMMUNOASSAY MARKET : BY END USER, LIFELINE CURVE 131
  • FIGURE 28 GLOBAL RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2022 137
  • FIGURE 29 GLOBAL RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 138
  • FIGURE 30 GLOBAL RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 138
  • FIGURE 31 GLOBAL RADIOIMMUNOASSAY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 139
  • FIGURE 32 GLOBAL RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022) 146
  • FIGURE 33 GLOBAL RADIOIMMUNOASSAY MARKET: BY REGION (2022) 147
  • FIGURE 34 GLOBAL RADIOIMMUNOASSAY MARKET: BY REGION (2023 & 2030) 147
  • FIGURE 35 GLOBAL RADIOIMMUNOASSAY MARKET: BY REGION (2022 & 2030) 148
  • FIGURE 36 GLOBAL RADIOIMMUNOASSAY MARKET: BY PRODUCT TYPE (2023-2030) 148
  • FIGURE 37 NORTH AMERICA RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022) 151
  • FIGURE 38 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022) 152
  • FIGURE 39 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030) 152
  • FIGURE 40 NORTH AMERICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030) 153
  • FIGURE 41 NORTH AMERICA RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030) 153
  • FIGURE 42 EUROPE RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022) 184
  • FIGURE 43 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022) 185
  • FIGURE 44 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030) 185
  • FIGURE 45 EUROPE RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030) 186
  • FIGURE 46 EUROPE RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030) 186
  • FIGURE 47 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022) 269
  • FIGURE 48 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022) 270
  • FIGURE 49 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030) 270
  • FIGURE 50 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030) 271
  • FIGURE 51 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030) 271
  • FIGURE 52 SOUTH AMERICA RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022) 358
  • FIGURE 53 SOUTH AMERICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022) 359
  • FIGURE 54 SOUTH AMERICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030) 359
  • FIGURE 55 SOUTH AMERICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030) 360
  • FIGURE 56 SOUTH AMERICA RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030) 360
  • FIGURE 57 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET: SNAPSHOT (2022) 384
  • FIGURE 58 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022) 385
  • FIGURE 59 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2023 & 2030) 385
  • FIGURE 60 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET: BY COUNTRY (2022 & 2030) 386
  • FIGURE 61 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY MARKET: PRODUCT TYPE (2023-2030) 386
  • FIGURE 62 GLOBAL RADIOIMMUNOASSAY MARKET: COMPANY SHARE 2022 (%) 434
  • FIGURE 63 NORTH AMERICA RADIOIMMUNOASSAY MARKET: COMPANY SHARE 2022 (%) 435
  • FIGURE 64 EUROPE RADIOIMMUNOASSAY MARKET: COMPANY SHARE 2022 (%) 436
  • FIGURE 65 ASIA-PACIFIC RADIOIMMUNOASSAY MARKET: COMPANY SHARE 2022(%) 437